Clinical Trial Update: Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating nimotuzumab in combination with radiotherapy for anal canal squamous cell carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of Anal Canal

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Dr. Te Vuong | Conditions: Squamous Cell Carcinoma of Anal Canal | Phase 2 | Status: TERMINATED